Syngen Biotech Co.,Ltd. (TPEX:8279)
Taiwan
· Delayed Price · Currency is TWD 110.00
-0.50 (-0.45%)
Mar 10, 2026, 1:30 PM CST
Syngen Biotech Ratios and Metrics
Market cap in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 2,995 | 3,144 | 3,442 | 4,119 | 4,390 | 3,062 | Upgrade
|
| Market Cap Growth | -12.30% | -8.66% | -16.45% | -6.17% | 43.36% | 4.63% | Upgrade
|
| Enterprise Value | 2,944 | 3,144 | 3,630 | 4,390 | 4,817 | 3,106 | Upgrade
|
| Last Close Price | 110.50 | 116.00 | 122.24 | 141.74 | 146.72 | 99.16 | Upgrade
|
| PE Ratio | 11.04 | 11.58 | 14.33 | 14.99 | 13.67 | 12.88 | Upgrade
|
| Forward PE | - | 13.20 | 13.20 | 13.20 | 13.20 | 13.20 | Upgrade
|
| PS Ratio | 1.40 | 1.47 | 1.71 | 2.24 | 2.27 | 2.08 | Upgrade
|
| PB Ratio | 1.26 | 1.33 | 1.54 | 1.93 | 2.20 | 1.73 | Upgrade
|
| P/TBV Ratio | 1.28 | 1.35 | 1.56 | 1.96 | 2.23 | 1.75 | Upgrade
|
| P/FCF Ratio | 11.70 | 12.28 | 11.96 | 12.74 | - | 11.14 | Upgrade
|
| P/OCF Ratio | 9.37 | 9.84 | 9.89 | 9.92 | 15.82 | 9.10 | Upgrade
|
| EV/Sales Ratio | 1.38 | 1.47 | 1.80 | 2.39 | 2.50 | 2.11 | Upgrade
|
| EV/EBITDA Ratio | 6.45 | 7.01 | 9.03 | 11.37 | 11.13 | 8.93 | Upgrade
|
| EV/EBIT Ratio | 8.79 | 9.62 | 11.97 | 14.50 | 13.29 | 11.03 | Upgrade
|
| EV/FCF Ratio | 11.51 | 12.29 | 12.61 | 13.58 | - | 11.30 | Upgrade
|
| Debt / Equity Ratio | 0.10 | 0.10 | 0.18 | 0.25 | 0.30 | 0.13 | Upgrade
|
| Debt / EBITDA Ratio | 0.50 | 0.50 | 0.95 | 1.34 | 1.34 | 0.65 | Upgrade
|
| Debt / FCF Ratio | 0.88 | 0.88 | 1.38 | 1.67 | - | 0.86 | Upgrade
|
| Net Debt / Equity Ratio | -0.02 | -0.02 | 0.03 | 0.08 | 0.18 | -0.04 | Upgrade
|
| Net Debt / EBITDA Ratio | -0.11 | -0.11 | 0.14 | 0.44 | 0.82 | -0.23 | Upgrade
|
| Net Debt / FCF Ratio | -0.20 | -0.20 | 0.20 | 0.53 | -1.16 | -0.29 | Upgrade
|
| Asset Turnover | 0.70 | 0.70 | 0.65 | 0.60 | 0.70 | 0.65 | Upgrade
|
| Inventory Turnover | 4.00 | 4.00 | 3.71 | 3.32 | 3.76 | 3.42 | Upgrade
|
| Quick Ratio | 1.42 | 1.42 | 1.47 | 1.29 | 1.00 | 1.68 | Upgrade
|
| Current Ratio | 2.20 | 2.20 | 2.22 | 1.94 | 1.55 | 2.43 | Upgrade
|
| Return on Equity (ROE) | 11.79% | 11.79% | 11.00% | 13.33% | 17.07% | 14.00% | Upgrade
|
| Return on Assets (ROA) | 6.67% | 6.67% | 6.12% | 6.13% | 8.26% | 7.75% | Upgrade
|
| Return on Invested Capital (ROIC) | 11.39% | 11.49% | 10.58% | 10.73% | 14.54% | 14.40% | Upgrade
|
| Return on Capital Employed (ROCE) | 12.90% | 12.90% | 11.80% | 12.00% | 15.40% | 14.10% | Upgrade
|
| Earnings Yield | 9.07% | 8.64% | 6.98% | 6.67% | 7.32% | 7.76% | Upgrade
|
| FCF Yield | 8.55% | 8.14% | 8.36% | 7.85% | -6.99% | 8.97% | Upgrade
|
| Dividend Yield | 4.37% | - | 4.09% | 3.53% | 3.41% | 4.03% | Upgrade
|
| Payout Ratio | 49.89% | 49.89% | 56.41% | 49.30% | 33.75% | 39.89% | Upgrade
|
| Buyback Yield / Dilution | -0.01% | -0.01% | - | 0.01% | 0.00% | 0.01% | Upgrade
|
| Total Shareholder Return | 4.35% | -0.01% | 4.09% | 3.54% | 3.41% | 4.04% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.